Viewing Study NCT05884320


Ignite Creation Date: 2025-12-25 @ 4:08 AM
Ignite Modification Date: 2026-01-28 @ 10:50 PM
Study NCT ID: NCT05884320
Status: RECRUITING
Last Update Posted: 2025-10-09
First Post: 2023-05-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module